HomeHEPA • NASDAQ
add
Hepion Pharmaceuticals Inc
Previous close
$0.43
Day range
$0.40 - $0.62
Year range
$0.39 - $117.70
Market cap
4.64M USD
Avg Volume
6.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.20M | -83.35% |
Net income | -1.55M | 86.01% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.20M | 83.32% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 406.41K | -97.25% |
Total assets | 1.61M | -91.08% |
Total liabilities | 3.48M | -67.85% |
Total equity | -1.86M | — |
Shares outstanding | 10.98M | — |
Price to book | -0.02 | — |
Return on assets | -112.80% | — |
Return on capital | -210.63% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.55M | 86.01% |
Cash from operations | -1.15M | 87.19% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.09M | 75.75% |
Free cash flow | 137.80K | 102.23% |
About
Founded
2013
Website
Employees
22
